#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12760	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2052	616.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1665	1665	T	710	T,C	640,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12760	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2052	616.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1399	1399	C	757	C,T	707,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23266	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3448	672.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1642	1642	A	788	A,G	729,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23266	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3448	672.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2276	2276	C	798	C	738	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23266	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3448	672.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2350	2350	A	787	A	737	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23266	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3448	672.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2902	2902	C	729	C,G	674,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	43882	blaTEM	861	861	99.88	blaTEM.l6.c17.ctg.1	1614	2707.4	0	.	p	.	0	P12S	NONSYN	34	36	CCC	307	309	TCC	3781;3788;3824	T,A;C,A;C,A	3503,2;3497,1;3524,1	.	Betalactam resistance
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	G5V	NONSYN	13	15	GGT	258	260	GTT	96;97;97	G;T;T	89;89;91	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	E12K	NONSYN	34	36	GAA	279	281	AAA	103;102;102	A;A;A	98;98;99	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	F31L	NONSYN	91	93	TTT	336	338	TTG	114;116;118	T;T;G	107;109;111	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	369	371	CAA	161;159;160	C;A;A	152;151;152	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	S75P	NONSYN	223	225	TCC	468	470	CCT	150;149;149	C;C;T	142;142;140	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	V87A	NONSYN	259	261	GTA	504	506	GCA	144;141;143	G;C;A	133;131;132	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	V130L	NONSYN	388	390	GTC	633	635	CTC	185;189;190	C;T;C	171;169;176	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	R135C	NONSYN	403	405	CGC	648	650	TGT	188;188;184	T;G;T	165;170;161	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	T137A	NONSYN	409	411	ACG	654	656	GCG	187;190;190	G;C;G	176;168;177	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	696	698	AAG	193;194;196	A;A;G	184;185;187	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	T152N	NONSYN	454	456	ACC	699	701	AAT	197;198;198	A;A;T	188;189;188	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	F218L	NONSYN	652	654	TTT	897	899	TTG	127;125;123	T;T;G	120;121;120	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	927	929	AGC	114;114;114	A;G;C,T	112;112;110,1	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	V251L	NONSYN	751	753	GTG	996	998	CTG	89;89;89	C;T;G	84;81;83	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1002	1004	TCC	86;86;87	T;C;C	81;79;82	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1017	1019	GTG	97;96;95	G;T;G	87;82;83	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1458	folP	852	852	93.78	folP.l15.c17.ctg.1	1487	97.4	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1068	1070	GCG	127;126;121	G;C;G	115;113;110	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5370	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3224	166.0	1	SNP	p	S91F	0	.	.	271	273	TCC	490	492	TCC	189;189;187	T;C;C	172;171;170	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5370	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3224	166.0	1	SNP	p	D95G	0	.	.	283	285	GAC	502	504	GAC	187;185;187	G;A;C	174;171;173	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5370	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3224	166.0	1	SNP	p	D95N	0	.	.	283	285	GAC	502	504	GAC	187;185;187	G;A;C	174;171;173	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1570	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1402	111.7	1	SNP	p	G45D	0	.	.	133	135	GGC	480	482	GGC	198;204;205	G;G;C	184;189;191	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	790	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	992	79.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4572	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2958	154.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1494	1496	ATC	195;198;198	A;T;C	173;179;178	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4572	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2958	154.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1647	1649	GCA	180;179;180	G;C;A	162;164;162	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4572	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2958	154.2	1	SNP	p	D86N	0	.	.	256	258	GAC	600	602	GAC	205;205;206	G;A;C	184;184;186	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4572	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2958	154.2	1	SNP	p	S87W	0	.	.	259	261	AGT	603	605	AGT	208;208;209	A;G,A;T	184;185,1;188	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4572	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2958	154.2	1	SNP	p	S87I	0	.	.	259	261	AGT	603	605	AGT	208;208;209	A;G,A;T	184;185,1;188	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4572	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2958	154.2	1	SNP	p	S87R	0	.	.	259	261	AGT	603	605	AGT	208;208;209	A;G,A;T	184;185,1;188	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4572	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2958	154.2	1	SNP	p	S88P	0	.	.	262	264	TCC	606	608	TCC	210;210;210	T;C;C	191;190;192	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3868	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2703	142.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1607	1609	GGC	195;192;193	G;G;C,T	176;173;174,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3740	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2603	143.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1361	1363	GCA	208;210;211	G;C;A	196;194;198	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3740	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2603	143.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1364	1366	ATC	211;212;211	A;T,G;C	197;198,1;199	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3740	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2603	143.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1376	1378	GTG	205;205;203	G;T;G	193;194;191	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3740	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2603	143.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1376	1378	GTG	205;205;203	G;T;G	193;194;191	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3740	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2603	143.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1880	1882	ACC	197;197;197	A;C;C,T	178;182;182,1	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3740	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2603	143.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1934	1936	GCG	178;176;176	G;C;G	152;132;138	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3740	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2603	143.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1934	1936	GCG	178;176;176	G;C;G	152;132;138	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3740	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2603	143.2	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2057	2059	GGT	156;156;156	G;G;T	145;143;143	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3740	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2603	143.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2066	2068	GGC	156;155;155	G,C;G;C	142,1;140;141	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3740	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2603	143.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2084	2086	CCG	144;143;137	C,G;C;G	103,5;106;95	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5292	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3006	175.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2042	porA	1146	1146	99.74	porA.l6.c30.ctg.1	1944	104.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	399	401	GGC	142;141;139	G;G;C,T	129;127;128,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2042	porA	1146	1146	99.74	porA.l6.c30.ctg.1	1944	104.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	581	581	C	158	C	143	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	100	102	TTA	49;50;50	T;T;A	45;46;46	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	145	147	CAT	54;51;51	C;A;T	51;50;49	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	148	150	AGT	51;52;52	A;G;T	50;51;51	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	157	159	TAC	53;53;53	T;A;C	51;51;51	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	R307E	NONSYN	919	921	AGA	247	249	GAA	21;21;20	G;A;A	21;21;20	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	259	261	GCA	23;21;21	G;C;A	23;21;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	268	270	ATC	19;20;19	A;T;C	19;19;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	274	276	TCG	18;18;18	T;C;G	17;17;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	280	282	GCC	17;17;17	G;C;C	15;17;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	283	285	AGC	17;17;17	A;G;C	15;15;16	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	286	288	GCC	16;17;17	G;C;C	14;15;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	282	porB1a	984	271	92.25	porB1a.l15.c17.ctg.2	353	31.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	292	294	GTT	15;14;13	G;T;T	12;12;9	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2664	porB1b	1035	1035	98.56	porB1b.l15.c4.ctg.1	1663	159.3	0	.	p	.	0	T206K	NONSYN	616	618	ACT	1098	1100	AAA	217;217;216	A;A;A	202;202;204	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2664	porB1b	1035	1035	98.56	porB1b.l15.c4.ctg.1	1663	159.3	0	.	p	.	0	.	MULTIPLE	622	623	AA	1105	1107	TCG	212;211;209	T;C,A;G	201;197,1;195	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2664	porB1b	1035	1035	98.56	porB1b.l15.c4.ctg.1	1663	159.3	0	.	p	.	0	I209fs	FSHIFT	625	625	A	1109	1109	A	209	A	203	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2664	porB1b	1035	1035	98.56	porB1b.l15.c4.ctg.1	1663	159.3	1	SNP	p	G120K	0	.	.	358	360	GGT	840	842	GGT	227;227;230	G;G;T	209;208;204	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2664	porB1b	1035	1035	98.56	porB1b.l15.c4.ctg.1	1663	159.3	1	SNP	p	A121D	0	.	.	361	363	GCC	843	845	GCC	233;231;229	G;C;C	211;209;206	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2664	porB1b	1035	1035	98.56	porB1b.l15.c4.ctg.1	1663	159.3	1	SNP	p	A121N	0	.	.	361	363	GCC	843	845	GCC	233;231;229	G;C;C	211;209;206	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9426	rpoB	4179	4179	99.95	rpoB.l15.c17.ctg.1	5032	186.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1104	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	899	121.6	1	SNP	p	V57M	1	.	.	169	171	ATG	461	463	ATG	238;240;245	A;T;G	214;217;222	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
